2 completed. .
Follow BioSig Technologies, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Redo AF Sub Study (of the Pure EP 2.0 Main Study) Pure-EP - Atrial Fibrillation Recurrent | Completed | BioSig Technologies, Inc. | 20 | 2021-03-03 | 2022-02-11 | |
| Novel Cardiac Signal Processing System PURE EP 2 - Cardiac Arrhythmia | Completed | BioSig Technologies, Inc. | 104 | 2019-11-12 | 2022-02-11 |
Arrhythmias, Cardiac (1) · Atrial Fibrillation (1) · Atrial Flutter (1) · Tachycardia, Ventricular (1)
United States (2)